Intellectual Property News & Topics - Secerna LLP

Morning Sickness Drugs Repurposing

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

News 17/09/2024

Recent breakthroughs in understanding the underlying causes of morning sickness offer exciting opportunities for drug repurposing. Learn how researchers can leverage existing medications to develop innovative treatments for this common pregnancy symptom.

Read more

Mrna Vaccines (1)

News 07/02/2024

Breaking Down the Code: Demystifying the Patent Battles Behind mRNA Vaccines

Ireland UPC

European, News, UPC 02/02/2024

Ireland to Vote on Joining the Unified Patent Court in June 2024

Matthew Feuer Image

Team news, Careers 30/01/2024

Matthew Feuer in profile

Secerna Office

News 29/01/2024

Join Secerna's Chemistry & Pharma Team as a Finalist/Newly Qualified Patent Attorney

Plant Baserd Meat

News 23/01/2024

Sustainability Through Innovation: IP Strategies for Meat Alternatives

Secerna Website Images 2023 (35)

Industry news, News 19/01/2024

Apple Watch Series 9 & Ultra 2 Grounded in US: Blood Oxygen Patent Dispute Takes Flight

Georgia EPO

European, Industry news, News 15/01/2024

New Route to Patent Protection in Georgia: European Applications Now Validated

Secerna Website Images 2023 (33)

Industry news, News 11/01/2024

Why AI-Generated Patent Applications Can Put Your Innovation at Risk

Protect Patent Portfolio

Industry news, News 02/01/2024

Patent Portfolio Management: The Key to Protecting Innovation

2 3 4 5 6 7 8 9 10 11 12